Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

75.57
Delayed Data
As of Sep 23
 -1.52 / -1.97%
Today’s Change
49.96
Today|||52-Week Range
110.75
-19.73%
Year-to-Date

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 111.00, with a high estimate of 180.00 and a low estimate of 65.00. The median estimate represents a +46.88% increase from the last price of 75.57.

Analyst Recommendations

The current consensus among 15 polled investment analysts is to Buy stock in Alnylam Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.15
Sales
$9.4M
Reporting Date
Nov 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -9.52%
 
 
 
 
 
 
Growthannually -37.37%
 
 
 
 
 
 

Sales

Growthquarterly 7.75%
 
 
 
 
 
 
Growthannually -8.32%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.